Georgia's Online Cancer Information Center

Atlanta clinical trials software startup raises $7.1M

Atlanta Business Chronicle

Florence, an Atlanta-based clinical trials software startup, has raised $7.1 million in a Series B round led by Fulcrum Equity Partners. Atrium Health and Bee Partners also participated in the round.

The startup, which assists clinical trials through software by managing document and data flow between research sites and sponsors, will use the funding for Florence’s product offerings. The company also plans to grow its sales, marketing and customer success teams, according to a news release.

“Clinical drug trials are slower and more expensive than ten years ago, halting access to cutting edge medicines,” Ryan Jones, CEO of Florence, said in a statement. “We are on a mission to fix this. Over the past five years, we’ve built the largest network of connected clinical trial sites through our eBinders platform. Our new partners, Fulcrum, Atrium, and Bee, will now allow us to digitally connect sites to pharmaceutical sponsors and clinical research organizations, creating a new type of research network that speeds progress.”

Currently, Florence has a network of 5,000-plus clinical trial sites and clinical trial sponsors. Their product Florence eBinders is used by 5,000-plus investigators to manage eRegulatory/eSource for over 1,200 studies. The company also provides solutions for eTMF and a virtual site workspace for monitoring, startup and document exchange.

The company reports that between July 2018 and July 2019, the activity of sponsors and CRO users on the Florence platform increased by 229%. Florence’s goal is to promote medical advancement while also reducing drug development costs and risks.

Florence was founded in 2014 by Jones, CTO Andres Garcia and Clinical Director Dr. Michael Kassin. Prior to this round, Florence raised a $1.7 million seed round from Bee Partners, a San Francisco-based early-stage venture firm, according to Crunchbase. 

View More

Media, News & Events

Despite pandemic, Georgia’s Colorectal Cancer Control Program making significant strides

Thanks to funding awarded by the Centers for Disease Control for five-years beginning July 2020, Georgia CORE and Augusta University are partners in the Georgia Colorectal Cancer Control Program, which is increasing CRC screenings in southeast and southwest Georgia.

3/23/2021

Chasing Cancer with Otis Brawley, MD & Ezekiel J. Emanuel, MD

Otis Brawley says he thinks coronavirus vaccine should be mandated like other vaccines in the U.S.

8/03/2021

Chasing Cancer with Otis Brawley, MD & Ezekiel J. Emanuel, MD

Otis Brawley says he thinks coronavirus vaccine should be mandated like other vaccines in the U.S.

8/03/2021

Cancer Center opens in Braselton

“This new collaborative space puts our patients’ needs front and center by providing a more cohesive environment with access to both medical oncology/hematology and radiation oncology services within steps of each other,” says Charles Nash III, MD, FACP, medical director of NGMC’s Cancer Services and medical oncologist with Longstreet Clinic (and Georgia CORE Board member).

6/29/2021

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofitthat leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.